(Q33812926)

29 July 2017

1 reference

title

Education and debate: Making regulation responsive to commercial interests: streamlining drug industry watchdogs (English)

1 reference

29 July 2017

John Abraham

1

1 reference

29 July 2017

Danielle Bardelay

2

1 reference

29 July 2017

Christophe Kopp

3

1 reference

29 July 2017

J D Kleinke

4

1 reference

29 July 2017

Emma Bennion

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

29 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

The BMJ

1 reference

29 July 2017

volume

325

1 reference

29 July 2017

issue

7373

1 reference

29 July 2017

page(s)

1164-1169

1 reference

Efficacy, safety, and cost of new anticancer drugs

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Patient care (empowerment): the view from a national society

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Whose illness is it anyway? Why patient perceptions matter.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Linking health technology assessment to practice. Interview by Abi Berger

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Approval of new drugs in the United States. Comparison with the United Kingdom, Germany, and Japan

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

The Drug Lag Issue: The Debate Seen from an International Perspective

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Adjusting Europe's drug regulation to public health needs.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124641

Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12433771

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.325.7373.1164

1 reference

29 July 2017

1 reference

29 July 2017

1 reference